Hydrated Chloral Market Intelligence Report (May 27, 2026)

I. Price Trends
1. Recent Quotations
- According to the Business Network’s benchmark price, hydrated chloral prices remained stable from May 20 to 26, 2026, with no significant fluctuations observed.
- Regional Price Differential: As the core production region—comprising Jiangsu and Shandong provinces—the East China region benefits from concentrated capacity and lower logistics costs, resulting in prices approximately 3–5% lower than those in other regions.

2. Historical Comparison
- The average price in May 2026 was approximately 4.2% higher year-on-year compared to May 2025, primarily driven by rising production costs attributable to tightening environmental regulations.
- In 2025, the annual price fluctuation range was RMB 7,800–8,500 per ton; in 2026, the price center shifted upward to RMB 8,200–8,600 per ton.

II. Supply-Demand Analysis
1. Supply Side
- Capacity Distribution: The East China region accounts for 45.3% of national capacity, with Jiangsu and Shandong provinces collectively contributing 32.1%, forming industrial clusters in Lianyungang, Weifang, and Zibo.
- New Capacity: In 2025, two new 10,000-ton-per-year continuous-production lines were commissioned at coastal bases—including Rugao Yangkou Port in Jiangsu—utilizing low-temperature catalytic hydration technology, reducing energy consumption by 38.7%. However, near-term output ramp-up remains limited.
- Environmental Constraints: The revised “Emission Limits for Pollutants from Chlorinated Organic Intermediates,” implemented in July 2025, mandates HCl absorption efficiency of ≥98.2%, driving the industry-wide average environmental investment share up to 4.5% and accelerating the exit of small- and medium-scale producers.

2. Demand Side
- Downstream Applications:
- Agrochemicals (65% share): Stable demand for chlorinated pesticides such as dicofol, supported by national food security strategies; agrochemical technical-grade output rose 5.3% year-on-year in 2025.
- Pharmaceuticals (22% share): Accelerating import substitution of high-purity chloral (e.g., 2,2,2-trichloroacetaldehyde); domestic self-sufficiency for pharmaceutical-grade products increased to 74% in 2025, generating a 15–20% price premium.
- Export Market: Exports totaled 36,000 tons in 2025, up 12.5% year-on-year, primarily destined for India, Brazil, and Vietnam; export average price rose 3.8%, reflecting enhanced international recognition of high-quality domestic products.

III. Competitive Landscape
1. Leading Enterprises
- Jiangsu EnHua Pharmaceutical: Leveraging the successful renewal of its right-zopiclone formulation onto the National Medical Insurance Catalogue, its in-house demand for chloral hydrate surged by 22.3%; its market share is projected to rise to 26.8% in 2026.
- Shandong Xinhua Pharmaceutical: Phase II of its integrated project has commenced operation; its 2026 capacity expanded to 1,100 tons/year. Combined with implementation of stringent pharmaceutical-grade quality control standards, it has consolidated its leadership in the high-end segment.
- Zhejiang Huahai Pharmaceutical: Optimized particle size distribution via AI-driven crystallization technology; maintained gross margin above 40.5% for external sales in 2026.

2. Market Concentration
- The CR3 (combined market share of the top three enterprises) reached 68.2% in 2025 and is expected to increase to 71.5% in 2026. New entrants must comply with both the “Green & Low-Carbon Fine Chemicals Catalogue” and dual-risk assessment requirements, significantly raising entry barriers.

IV. Policy & Cost Factors
1. Policy Impact
- Environmental Regulation: In 2025, the Ministry of Ecology and Environment included chloral in the “Key Monitored List of Toxic and Hazardous Air Pollutants,” compelling enterprises to upgrade pollution control systems to combined RTO incineration + alkaline scrubbing configurations, thereby lowering unit product comprehensive energy consumption by 5.4% year-on-year.
- Industrial Support: The 2025 “Fine Chemical Industry High-Quality Development Special Action Plan” explicitly designates chloral as the top-priority item on the “Critical Intermediate Assurance List” for pharmaceuticals and agrochemicals, offering targeted financial subsidies to enterprises achieving ≥95% annual compliance and production rate for three consecutive years.

2. Cost Pressure
- Industry-wide wastewater reuse rate rose to 76.3% in 2025—up 9.1 percentage points from 2024—but stricter HCl absorption efficiency standards increased per-ton treatment cost by ~RMB 200.

V. Forward Outlook
1. Price Trend
- Short-Term: Prices are expected to remain stable within RMB 8,200–8,600 per ton in June 2026; the East China region may experience marginal downward pressure due to its concentrated supply base.
- Medium-to-Long Term: The industry’s CAGR is projected at 6.7% from 2026 to 2030, reaching a total market size of RMB 6.215 billion by 2030; however, annual price growth will gradually moderate to 3–5%, offset by technological upgrades and economies of scale mitigating cost pressures.

2. Supply-Demand Balance
- Consumption-to-production matching ratio in 2026 is expected to exceed 98%, with inventory turnover days remaining stable around 42 days—indicating healthy and orderly market operations.
- Export markets continue expanding: 2026 exports are anticipated to surpass 40,000 tons, with India and Southeast Asia collectively accounting for over 60% of export volume.

3. Risk Factors
- Environmental Policy: Further tightening of emission standards could trigger regional production suspensions or rectification campaigns, causing short-term supply tightness.
- Geopolitical Conflict: Disruptions in Middle Eastern supply chains may push up raw material costs (e.g., chlor-alkali), transmitting upward pricing pressure to downstream products.